Chemoinformaics analysis of Dehydrodiconiferyl Alcohol
| Molecular Weight | 358.39 | nRot | 6 |
| Heavy Atom Molecular Weight | 336.214 | nRig | 17 |
| Exact Molecular Weight | 358.142 | nRing | 3 |
| Solubility: LogS | -3.487 | nHRing | 1 |
| Solubility: LogP | 1.842 | No. of Aliphatic Rings | 1 |
| Acid Count | 0 | No. of Aromatic Rings | 2 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 0 |
| Atoms Count | 48 | No. of Aliphatic Hetero Cycles | 1 |
| No. of Heavy Atom | 26 | No. of Aromatic Carbocycles | 2 |
| nHetero | 6 | No. of Aromatic Hetero Cycles | 0 |
| nBridge Head | 0 | No. Saturated Carbocycles | 0 |
| No. of Hydrogen atom | 22 | No. of Saturated Hetero Cycles | 0 |
| No. of Carbon atom | 20 | No. of Saturated Rings | 0 |
| No. of Nitrogen atom | 0 | No. of Arom Atom | 12 |
| No. of Oxygen atom | 6 | No. of Arom Bond | 12 |
| nHA | 6 | APOL | 52.8814 |
| nHD | 3 | BPOL | 27.2786 |
| QED | 0.736 |
| Synth | 3.429 |
| Natural Product Likeliness | 1.978 |
| NR-PPAR-gamma | 0.53 |
| Lipinski | Accepted |
| Pfizer | Accepted |
| GSK | Accepted |
| Golden Triangle | Accepted |
| Pgp-inh | 0.535 |
| Pgp-sub | 0.008 |
| HIA | 0.017 |
| CACO-2 | -4.828 |
| MDCK | 0.0000114 |
| BBB | 0.438 |
| PPB | 0.939476 |
| VDSS | 0.865 |
| FU | 0.0752066 |
| CYP1A2-inh | 0.056 |
| CYP1A2-sub | 0.699 |
| CYP2c19-inh | 0.031 |
| CYP2c19-sub | 0.784 |
| CYP2c9-inh | 0.088 |
| CYP2c9-sub | 0.734 |
| CYP2d6-inh | 0.018 |
| CYP2d6-sub | 0.835 |
| CYP3a4-inh | 0.549 |
| CYP3a4-sub | 0.843 |
| CL | 8.805 |
| T12 | 0.685 |
| hERG | 0.053 |
| Ames | 0.139 |
| ROA | 0.244 |
| SkinSen | 0.932 |
| Carcinogencity | 0.332 |
| EI | 0.016 |
| Respiratory | 0.302 |
| NR-Aromatase | 0.8 |
| Antiviral | Yes |
| Prediction | 0.624747 |